Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2024 1
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy of Nirmatrelvir/ritonavir in reducing the risk of severe outcome in patients with SARS-CoV-2 infection: a real-life full-matched case-control study (SAVALO Study).
Gentile I, Giaccone A, Scirocco MM, Di Brizzi F, Cuccurullo F, Silvitelli M, Ametrano L, Alfè FA, Pietroluongo D, Irace I, Chiariello M, De Felice N, Severino S, Viceconte G, Schiano Moriello N, Maraolo AE, Buonomo AR, Scotto R; Federico II COVID team. Gentile I, et al. Among authors: irace i. BMC Infect Dis. 2024 Dec 18;24(1):1434. doi: 10.1186/s12879-024-10303-5. BMC Infect Dis. 2024. PMID: 39696011 Free PMC article.
Efficacy of Molnupiravir in Reducing the Risk of Severe Outcomes in Patients with SARS-CoV-2 Infection: A Real-Life Full-Matched Case-Control Study (SAVALO Study).
Gentile I, Scotto R, Scirocco MM, Di Brizzi F, Cuccurullo F, Silvitelli M, Ametrano L, Alfè FA, Pietroluongo D, Irace I, Chiariello M, De Felice N, Severino S, Viceconte G, Schiano Moriello N, Maraolo AE, Buonomo AR, Giaccone A, On Behalf Of Federico Ii Covid Team. Gentile I, et al. Among authors: irace i. Microorganisms. 2025 Mar 15;13(3):669. doi: 10.3390/microorganisms13030669. Microorganisms. 2025. PMID: 40142561 Free PMC article.
Correction: Efficacy of Nirmatrelvir/ritonavir in reducing the risk of severe outcome in patients with SARS-CoV-2 infection: a real-life full-matched case-control study (SAVALO Study).
Gentile I, Giaccone A, Scirocco MM, Di Brizzi F, Cuccurullo F, Silvitelli M, Ametrano L, Alfè FA, Pietroluongo D, Irace I, Chiariello M, De Felice N, Severino S, Viceconte G, Moriello NS, Maraolo AE, Buonomo AR, Scotto R; Federico II COVID team. Gentile I, et al. Among authors: irace i. BMC Infect Dis. 2025 Apr 29;25(1):633. doi: 10.1186/s12879-025-11043-w. BMC Infect Dis. 2025. PMID: 40301747 Free PMC article. No abstract available.